Ebola Center

The US Food and Drug Administration (FDA) has approved the first-ever medication to treat Ebola virus.

In an early, phase I trial, researchers think they have found an Ebola vaccine combination that could offer at least partial protection.

The recent West African epidemic has intensified the search for an effective Ebola vaccine. And researchers are now saying they may be one step closer to finding one.

A new discovery may have given scientists a glimpse into the mechanisms behind Ebola.

The US is set to withdraw nearly all of its troops deployed to fight the Ebola outbreak in West Africa — a sign of the disease's recent slowdown. Officials cautioned, however, that the fight isn't over.

As new cases of Ebola in Liberia begin to wane, GlaxoSmithKline (GSK) has dispatched its first shipment of an experimental Ebola vaccine in an effort to put a stop to the spread of the virus.

While the Ebola epidemic in West Africa is far from over, one country is free of the virus.

The US Food and Drug Administration (FDA) today approved an Ebola test that could cut the time it takes to detect Ebola in a patient in half. This new lab test can be completed within three hours.

Researchers can safely study the highly contagious Ebola virus by following the proper safety protocol, which includes wearing a face shield. But if errors are made, those researchers may face some serious consequences.

In the fight against Ebola in West Africa, health workers are continually putting themselves at risk to treat infected patients, while pharmaceutical companies work vigorously to find an effective vaccine. Parties on both fronts have hit a stumbling block.

Time magazine's selection for Person of the Year 2014 isn't just one outstanding man or woman — it's the thousands of men and women who have fought what is now the largest Ebola outbreak in history.

The United States's Ebola readiness just got a boost. Now, 35 hospitals across the country are equipped to treat patients with Ebola. And more hospitals are expected to be ready in the coming weeks.

A surgeon infected with Ebola in West Africa is headed to the Nebraska Medical Center in Omaha for treatment.

Despite recent decreases in new Ebola cases in hard-hit Liberia, the fight against Ebola isn't over. After recent case spikes in Guinea and Sierra Leone, health officials have taken several new measures to combat the virus both abroad and in the US.

After reports last week that the rate of new Ebola cases in Liberia was slowing, new reports indicated a spike in cases in Guinea and Sierra Leone. Meanwhile, Texas, where a few cases broke out in October, hasn't seen a new case in 21 days.

Recent reports suggest that the new Ebola case rate in Liberia, one of the hardest-hit countries in the Ebola outbreak in West Africa, may be slowing. But health officials remain cautious about relaxing the fight against the virus.

Health officials announced Friday that millions of doses of two experimental Ebola vaccines could be ready to use in 2015. If they prove effective, the vaccines could be a boost to the fight against the current West African Ebola outbreak that has claimed more than 4,800 lives.

A New York City doctor who recently returned from treating Ebola patients in West Africa tested positive for Ebola Thursday. Health officials placed the patient in isolation and began the search for people who might have come into contact with him.

While treating a Liberian man infected with Ebola, two Dallas nurses became infected with the virus. Now, the Centers for Disease Control and Prevention (CDC) has tightened its guidelines for Ebola treatment.

More than 40 people in Texas breathed a sigh of relief Monday — they had been taken off a watch list for Ebola infection after coming into contact with the first patient diagnosed in the US, Thomas Eric Duncan.